Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-02-14

FDA Approved: VOLTAREN ARTHRITIS PAIN — Supplemental Application (Haleon US Holdings LLC)

View source ↗

Summary

FDA approves a supplemental application for Voltaren Arthritis Pain (diclofenac sodium) by Haleon US Holdings LLC to expand the labeling for arthritis pain reli…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Voltaren Arthritis Pain (Diclofenac sodium)

Snippet

SUPPL AP for VOLTAREN ARTHRITIS PAIN (DICLOFENAC SODIUM)